May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Exclusion of Six Candidate Genes as Genetic Modifiers of Disease Expression in Canine XLPRA1, a Model for Human X–Linked Retinitis Pigmentosa 3 (RP3)
Author Affiliations & Notes
  • R. Guyon
    School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
  • S.E. Pierce–Kelling
    Baker Institute, Cornell, Ithaca, NY
  • C.J. Zeiss
    School of Medicine, Yale, New Haven, CT
  • G.M. Acland
    Baker Institute, Cornell, Ithaca, NY
  • G.D. Aguirre
    School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
  • Footnotes
    Commercial Relationships  R. Guyon, None; S.E. Pierce–Kelling, None; C.J. Zeiss, None; G.M. Acland, None; G.D. Aguirre, None.
  • Footnotes
    Support  NIH EY13132, EY6855, The Foundation Fighting Blindness, The Morris Animal Foundation/The Seeing Eye Inc., The Van Sloun Fund for Canine Genetic Research
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3256. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. Guyon, S.E. Pierce–Kelling, C.J. Zeiss, G.M. Acland, G.D. Aguirre; Exclusion of Six Candidate Genes as Genetic Modifiers of Disease Expression in Canine XLPRA1, a Model for Human X–Linked Retinitis Pigmentosa 3 (RP3) . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3256.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : A stop mutation in RPGRORF15 causes XLPRA1. There is extensive phenotypic variability in the disease even though all colony dogs have inherited the same stable mutation derived from one mutant X–chromosome. We have investigated known (RPGRIP1, RANBP2, NPM1, PDE6D, NPHP5) and potential (ABCA4) RPGR interacting genes as possible genetic modifiers of the disease.

Methods: : A pedigree derived from an affected male outcrossed to unrelated normal mix bred or purebred females was used. Morphologic examination revealed phenotypic variability in the affected dogs (1 mild, 9 moderate, 14 severe), possibly due to a secondary modifier gene acting as an autosomal semi–dominant trait. SNPs and indel–containing markers were designed based on the canine sequence and the Broad Institute SNP library. The segregation of the alleles was followed throughout the pedigree, and allelic phase was identified for each candidate gene, and their association with the level of severity of the disease estimated. Primers were derived from ESTs and predicted transcripts to assess the retinal expression of the 6 genes of interest in normal and affected retinas using semi–quantitative RT–PCR.

Results: : For each of the 6 genes, 4 to 7 informative SNPs and indel–containing markers were selected from upstream, downstream and intronic regions. These markers spanned a genomic region ranging from 57 to 111 kb, and covering the entire gene. The genotyping of these markers allowed the identification of 4 to 6 distinct allelic phases. None of these allelic phases co–segregates with the phenotype in a semi–dominant manner, excluding a modifying role of the genes investigated. No significant difference in the retinal expression levels of the candidate genes was seen between normal and affected dogs.

Conclusions: : The phenotypic variability observed in XLPRA1 affected dogs having the same mutation inherited from a single mutant X–chromosome cannot be explained by one of the 6 candidate genes acting as a semi–dominant genetic modifier. The RPGRORF15 stop mutation does not affect the retinal expression of these genes.

Keywords: retinal degenerations: hereditary • gene modifiers • candidate gene analysis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×